icon- folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Denver, CO 80202, United States
February 22 - 25, 2026
 		Back grey_arrow_rt.gif
 
 
 
DOR/ISL (100/0.25 mg) vs BIC/FTC/TAF for Initial HIV-1 Therapy:
Week 48 Results of a Phase III Study
 
 
  CROI 2026 Feb 22-25 Denver

0225261

0225262

0225263

0225264

0225265

0225266

0225267

0225268